Phase 3 trial of subcutaneous epcoritamab in combination with rituximab and lenalidomide (R(2)) vs R(2) among patients with relapsed or refractory follicular lymphoma (EPCORE FL-1) Meeting Abstract
| Authors: | Falchi, L.; Morschhauser, F.; Gribben, J. G.; Huang, H.; Dinh, M.; Conlon, R.; Chen, X.; Elliot, B.; Seymour, J. F. |
| Abstract Title: | Phase 3 trial of subcutaneous epcoritamab in combination with rituximab and lenalidomide (R(2)) vs R(2) among patients with relapsed or refractory follicular lymphoma (EPCORE FL-1) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 9338 |
| End Page: | 9339 |
| Language: | English |
| ACCESSION: | WOS:000893230302151 |
| DOI: | 10.1182/blood-2022-157584 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
